These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3958926)

  • 1. Hydrophilic cyclodextrin derivatives enable effective oral administration of steroidal hormones.
    Pitha J; Harman SM; Michel ME
    J Pharm Sci; 1986 Feb; 75(2):165-7. PubMed ID: 3958926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. gamma-Cyclodextrin:testosterone complex suitable for sublingual administration.
    Pitha J; Anaissie EJ; Uekama K
    J Pharm Sci; 1987 Oct; 76(10):788-90. PubMed ID: 3430342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amorphous water-soluble derivatives of cyclodextrins: nontoxic dissolution enhancing excipients.
    Pitha J; Pitha J
    J Pharm Sci; 1985 Sep; 74(9):987-90. PubMed ID: 4067854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppositories containing cyclodextrin complexes. Part 2: Dissolution and absorption studies.
    Szente L; Apostol I; Gerlóczy A; Szejtli J
    Pharmazie; 1985 Jun; 40(6):406-7. PubMed ID: 4034649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of the oral bioavailability of digitalis glycosides by cyclodextrin complexation.
    Uekama K; Fujinaga T; Hirayama F; Otagiri M; Yamasaki M; Seo H; Hashimoto T; Tsuruoka M
    J Pharm Sci; 1983 Nov; 72(11):1338-41. PubMed ID: 6644599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal absorption enhancement of 17 beta-estradiol by dimethyl-beta-cyclodextrin in rabbits and rats.
    Hermens WA; Deurloo MJ; Romeyn SG; Verhoef JC; Merkus FW
    Pharm Res; 1990 May; 7(5):500-3. PubMed ID: 2367318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of bioavailability of cinnarizine from its beta-cyclodextrin complex on oral administration with DL-phenylalanine as a competing agent.
    Tokumura T; Tsushima Y; Kayano M; Machida Y; Nagai T
    J Pharm Sci; 1985 Apr; 74(4):496-7. PubMed ID: 3999017
    [No Abstract]   [Full Text] [Related]  

  • 8. [Enhancement of drug absorption with cyclodextrin inclusion complexes].
    Szejtli J; Gerlóczy A; Szente L; Bánky-Elöd E; Sebestyén G; Fónagy A; Kurcz M
    Acta Pharm Hung; 1979 Sep; 49(5):207-21. PubMed ID: 532664
    [No Abstract]   [Full Text] [Related]  

  • 9. [Molecular cavity filling and tabletting with beta-cyclodextrin].
    Hüttenrauch R; Fricke S
    Pharmazie; 1985 May; 40(5):361-2. PubMed ID: 4034643
    [No Abstract]   [Full Text] [Related]  

  • 10. [Improvement of bioavailability of menaquinone-4 by dimethyl-beta-cyclodextrin complexation following oral administration].
    Horiuchi Y; Kikuchi M; Hirayama F; Uekama K; Ueno M; Ijitsu T
    Yakugaku Zasshi; 1988 Nov; 108(11):1093-100. PubMed ID: 3251020
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of roll mixing with beta-cyclodextrin on enhancing solubilities of water insoluble drugs.
    Nozawa Y; Yamamoto A
    Pharm Acta Helv; 1989; 64(1):24-9. PubMed ID: 2717647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion complex formation of 1,8-dihydroxyanthraquinone with cyclodextrins in aqueous solution and in solid state.
    Smulevich G; Feis A; Mazzi G; Vincieri FF
    J Pharm Sci; 1988 Jun; 77(6):523-6. PubMed ID: 3171933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiol.
    Loftsson T; Bodor N
    Acta Pharm Nord; 1989; 1(4):185-94. PubMed ID: 2590460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Spray embedding of vinpocetin with beta-cyclodextrin].
    Kata M; György E
    Pharmazie; 1982 May; 37(5):386-7. PubMed ID: 7111372
    [No Abstract]   [Full Text] [Related]  

  • 15. Amorphous water-soluble cyclodextrin derivatives: 2-hydroxyethyl, 3-hydroxypropyl, 2-hydroxyisobutyl, and carboxamidomethyl derivatives of beta-cyclodextrin.
    Irie T; Fukunaga K; Yoshida A; Uekama K; Fales HM; Pitha J
    Pharm Res; 1988 Nov; 5(11):713-7. PubMed ID: 3247276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative structure-stability relationships among inclusion complexes of cyclodextrins. I: Barbituric acid derivatives.
    Lopata A; Darvas F; Stadler-Szóke A; Szejtli J
    J Pharm Sci; 1985 Feb; 74(2):211-3. PubMed ID: 3989695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of dipyridamole-beta-cyclodextrin complex in dogs.
    Stracciari GL; Malvisi J; Anfossi P; Fregnan GB
    Arch Int Pharmacodyn Ther; 1989; 300():7-13. PubMed ID: 2619427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and investigating of tablets containing furosemide and beta-cyclodextrin.
    Kata M; Haragh L; Pintye-Hódi K
    Acta Pharm Hung; 1990 Jan; 60(1):40-5. PubMed ID: 2327256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety Profile of Diclofenac/Cyclodextrin and Progesterone/Cyclodextrin Formulations: A Review of the Literature Data.
    Scavone C; Bonagura AC; Fiorentino S; Cimmaruta D; Cenami R; Torella M; Fossati T; Rossi F
    Drugs R D; 2016 Jun; 16(2):129-40. PubMed ID: 26939533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential use of cyclodextrins in parenteral formulations.
    Brewster ME; Simpkins JW; Hora MS; Stern WC; Bodor N
    J Parenter Sci Technol; 1989; 43(5):231-40. PubMed ID: 2681643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.